Table 3.
The EGFR kinase inhibitory activity of substituted 1,3,4-oxadiazoles.
| Compd. No. | IC50 (µM) |
|---|---|
| 116 | 0.4123 ± 0.022 |
| 117 | 0.2757 ± 0.013 |
| 118 | 1.1289 ± 0.045 |
| Erlotinib (Standard) | 0.4178 ± 0.014 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.